Carisoprodol tablets USP, 350 mg are white, round, debossed MP 58 on one side and blank on the other side.
|Bottles of 20||NDC 53489-110-60|
|Bottles of 30||NDC 53489-110-07|
|Bottles of 60||NDC 53489-110-06|
|Bottles of 100||NDC 53489-110-01|
|Bottles of 500||NDC 53489-110-05|
|Bottles of 1000||NDC 53489-110-10|
Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room Temperature]
DISPENSE IN TIGHT, LIGHT-RESISTANT CONTAINER.
Patients should be advised to contact their physician if they experience any adverse reactions to carisoprodol.
Patients should be advised that carisoprodol may cause drowsiness and/or dizziness, and has been associated with motor vehicle accidents. Patients should be advised to avoid taking carisoprodol before engaging in potentially hazardous activities such as driving a motor vehicle or operating machinery [see Warnings and Precautions (5.1) ].
Patients should be advised to avoid alcoholic beverages while taking carisoprodol and to check with their doctor before taking other CNS depressants such as benzodiazepines, opioids, tricyclic antidepressants, sedating antihistamines, or other sedatives [see Warnings and Precautions (5.1) ].
Patients should be advised that treatment with carisoprodol should be limited to acute use (up to two or three weeks) for the relief of acute, musculoskeletal discomfort. In the post-marketing experience with carisoprodol, cases of dependence, withdrawal, and abuse have been reported with prolonged use. If the musculoskeletal symptoms still persist, patients should contact their healthcare provider for further evaluation.
MUTUAL PHARMACEUTICAL COMPANY, INC.
Philadelphia, PA 19124 USA
Rev 08, February 2014
PRINCIPAL DISPLAY PANEL — 100 Tablet Label
MUTUAL PHARMACEUTICAL CO., INC. PHILADELPHIA, PA 19124 USA
|CARISOPRODOL carisoprodol tablet|
|Labeler — Mutual Pharmaceutical Company, Inc. (121735955)|
Revised: 02/2014 Mutual Pharmaceutical Company, Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.